Description

FOXO4-DRI (Proxofim) Peptide Vials

Introduction

FOXO4-DRI (Proxofim) Vials are a specialized research product designed for scientific exploration. It is crucial to note that these vials are intended strictly for research purposes and are not for human consumption. The primary focus of this product is the investigation of FOXO4-DRI, a promising peptide, and its potential applications in diverse scientific disciplines.

Key Characteristics

Each vial contains a carefully purified form of FOXO4-DRI, ensuring a high standard of purity and consistency. These characteristics make FOXO4-DRI (Proxofim) Vials an ideal tool for researchers delving into the biological roles and effects of FOXO4-DRI in controlled laboratory settings.

Research Applications

FOXO4-DRI (Proxofim) Vials find application in various research domains, including molecular biology, cell signaling, and studies related to aging, heart health, and metabolic disorders. Researchers can utilize these vials to explore the molecular mechanisms associated with FOXO4-DRI and its potential implications in various biological processes.

Research Benefits

FOXO4-DRI on Chemotoxicity and Aging

Research studies have indicated that FOXO4-DRI may influence chemotoxicity and aging processes. By targeting specific cellular pathways, FOXO4-DRI presents a potential avenue for mitigating the adverse effects of chemotoxicity and exploring interventions for age-related conditions.

FOXO4-DRI on Heart Attack

Scientific investigations have explored the potential impact of FOXO4-DRI on heart health, particularly in the context of heart attacks. Preliminary findings suggest that FOXO4-DRI may play a role in influencing cellular processes associated with heart health, warranting further investigation in the realm of cardiovascular research.

FOXO4-DRI on Diabetes Mellitus

Emerging studies have suggested potential links between FOXO4-DRI and diabetes mellitus. FOXO4-DRI’s influence on cellular pathways associated with metabolic regulation makes it a subject of interest for researchers exploring interventions and understanding the complexities of diabetes mellitus.

Summary

FOXO4-DRI (Proxofim) Vials serve as a valuable research tool for scientists investigating the diverse roles of FOXO4-DRI in chemotoxicity, aging, heart health, and diabetes mellitus. Adhering to stringent research ethics, these vials provide a foundation for advancing our understanding of FOXO4-DRI and its implications in various biological processes. Researchers are encouraged to explore the provided references for a comprehensive grasp of the existing knowledge in these research areas.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Baar MP, Brandt RMC, Putavet DA, Klein JDD, Derks KWJ, Bourgeois BRM, Stryeck S, Rijksen Y, van Willigenburg H, Feijtel DA, van der Pluijm I, Essers J, van Cappellen WA, van IJcken WF, Houtsmuller AB, Pothof J, de Bruin RWF, Madl T, Hoeijmakers JHJ, Campisi J, de Keizer PLJ. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017 Mar 23;169(1):132-147.e16. doi: 10.1016/j.cell.2017.02.031. PMID: 28340339; PMCID: PMC5556182. [Read More]
2. Chuang PY, Dai Y, Liu R, He H, Kretzler M, Jim B, Cohen CD, He JC. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One. 2011;6(8):e23566. doi: 10.1371/journal.pone.0023566. Epub 2011 Aug 17. PMID: 21858169; PMCID: PMC3157434. [Read More]
3. Zhu M, Goetsch SC, Wang Z, Luo R, Hill JA, Schneider J, Morris SM Jr, Liu ZP. FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1. Circ Res. 2015 Nov 6;117(11):967-77. doi: 10.1161/CIRCRESAHA.115.306919. Epub 2015 Oct 5. PMID: 26438688; PMCID: PMC4710860. [Read More]